Strong PSMA Radioligand Uptake by Rectal Carcinoma: Who Put the "S" in PSMA?
- PMID: 27997423
- DOI: 10.1097/RLU.0000000000001484
Strong PSMA Radioligand Uptake by Rectal Carcinoma: Who Put the "S" in PSMA?
Erratum in
-
Strong PSMA Radioligand Uptake by Rectal Carcinoma: Who Put the "S" in PSMA? Evaluation and Preliminary Experience on 16 Patients: Erratum.Clin Nucl Med. 2017 Oct;42(10):820. doi: 10.1097/RLU.0000000000001826. Clin Nucl Med. 2017. PMID: 28873077 No abstract available.
Abstract
We present a case of a 71-year-old patient with newly diagnosed rectal adenocarcinoma and hepatic metastases. Restaging after chemotherapy revealed a good response of the rectal primary while liver metastases were progressive. As the patient also had a history of prostate cancer, a Ga-PSMA-HBED-CC PET/CT scan was performed to noninvasively further assess hepatic metastases. However, a definite differentiation between tumor entities was not possible because not only the liver metastases but also the rectal primary showed radioligand uptake (moderate and strong, respectively). Consecutive liver biopsy revealed a poorly differentiated adenocarcinoma of intestinal origin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous